Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04899102 · ClinicalTrials.gov registry record · NA
Intermittent Fasting for NAFLD in Adults
A NA study of Non-alcoholic Fatty Liver Disease and Fatty Liver, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT04899102: Recruiting NA study of Non-alcoholic Fatty Liver Disease and Fatty Liver, sponsored by Massachusetts General Hospital.
NCT04899102 is a NA study of Non-alcoholic Fatty Liver Disease and Fatty Liver that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 25 participants, below the 177-participant average among 57 other Non-alcoholic Fatty Liver Disease trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04899102, a NA study of Non-alcoholic Fatty Liver Disease and Fatty Liver, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
NAFLD is a growing threat to public health. Currently, there is a significant need for highly effective treatments for NAFLD. Non-obese NAFLD (BMI\<30kg/m2) is an increasingly recognized condition, sometimes described as "lean NAFLD". Intermittent Fasting (IF) may be uniquely beneficial in non-obese NAFLD. The purpose of this study is to identify non-pharmacologic, lifestyle-based methods of NAFLD treatment within non-obese adults.
Primary Outcome
Liver Fat Content as measured by hydrogen-magnetic resonance spectroscopy (H-MRS)
Conditions Studied
Interventions
- BEHAVIORAL Time-Restricted, Intermittent Fasting
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2022-02-01 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
What NCT04899102 shows while recruiting
NCT04899102 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 177-participant average among 57 other Non-alcoholic Fatty Liver Disease trials with a reported enrollment target (86% lower).
The record links to 5 conditions, with Non-alcoholic Fatty Liver Disease appearing as the primary indexed condition, and to 1 intervention - of which Time-Restricted, Intermittent Fasting is the first listed.
NCT04899102 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04899102 about?
NCT04899102 is a clinical study titled "Intermittent Fasting for NAFLD in Adults". NAFLD is a growing threat to public health. Currently, there is a significant need for highly effective treatments for NAFLD. Non-obese NAFLD (BMI\<30kg/m2) is an increasingly recognized condition, sometimes described as "lean NAFLD". Intermittent Fasting (IF) may be uniquely beneficial in non-obese...
What is the current status of trial NCT04899102?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2022-02-01. Estimated completion is 2026-07-31.
What conditions does trial NCT04899102 study?
This clinical trial studies the following conditions: Non-alcoholic Fatty Liver Disease, Fatty Liver, Liver Fat, Fatty Liver, Nonalcoholic, Intermittent Fasting.
What interventions are being tested in trial NCT04899102?
The interventions under investigation include: Time-Restricted, Intermittent Fasting (BEHAVIORAL).
Who is sponsoring clinical trial NCT04899102?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04899102 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-alcoholic Fatty Liver Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04899102's enrollment target sits among peer trials
25 51st of 57 higher than 6 of 57 other Non-alcoholic Fatty Liver Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Non-alcoholic Fatty Liver Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Moderately Carbohydrate-restricted Diet to Treat NAFLD in Adolescents
RECRUITING · NA
-
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
RECRUITING · NA
-
The Olmsted NAFLD Epidemiology Study (TONES)
RECRUITING · NA
-
Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease
RECRUITING · NA
-
Role of Immune System in Obesity-related Inflammation and Cardiometabolic Risk
ACTIVE NOT RECRUITING · NA
-
Prevention of NAFLD in Hispanic Children
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI